Which has the lower trailing P/E, JAZZ or SOLV?

SOLV has the lower trailing P/E: JAZZ trades at 15.82 and SOLV at 10.63. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, JAZZ or SOLV?

Over the past five years, JAZZ grew revenue faster — JAZZ at a 11.87% CAGR versus SOLV at 2.72%.

Is JAZZ or SOLV more profitable?

JAZZ runs the higher net margin — JAZZ at 20.45% versus SOLV at 17.26%.

Jazz Pharmaceuticals plc (JAZZ) vs Solventum Corporation (SOLV)

A side-by-side comparison of Jazz Pharmaceuticals plc and Solventum Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

JAZZ

Jazz Pharmaceuticals plc

$14.54B

$231.39HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

SOLV

Solventum Corporation

$15.07B

$87.04HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — JAZZ vs SOLV

growth of $100 · dividends reinvested · last 3y

JAZZ +90.2% (+23.9%/yr)SOLV +10.0% (+3.2%/yr)JAZZ compounded faster over this window

JAZZ SOLV

JAZZ vs SOLV: by the numbers

•SOLV is the larger company ($15.07B vs $14.54B market cap).
•SOLV trades at the lower trailing earnings multiple (10.63 vs 15.82 P/E), one valuation lens rather than an overall verdict.
•JAZZ converts more revenue to profit (20.45% vs 17.26% net margin).
•JAZZ grew revenue faster over the past five years (11.87% vs 2.72% CAGR).

Metrics side by side

Valuation

Metric	JAZZ	SOLV
P/E ratio	15.82	10.63
Forward P/E	9.27	12.15
PEG ratio	N/A	1.74
P/S ratio	3.16	1.81
P/B ratio	3.03	3.14
EV / EBITDA	8.74	7.01
FCF yield	10.61%	N/A

Profitability

Metric	JAZZ	SOLV
Gross margin	84.67%	54.69%
Operating margin	5.26%	24.99%
Net margin	20.45%	17.26%
ROE	19.59%	29.88%
ROIC	14.48%	15.85%

Growth (annualized)

Metric	JAZZ	SOLV
Revenue CAGR (5Y)	11.87%	2.72%
EPS CAGR (5Y)	N/A	6.26%
FCF CAGR (5Y)	15.39%	N/A
Total return CAGR (5Y)	13.01%	N/A

Frequently asked

Which has the lower trailing P/E, JAZZ or SOLV?: SOLV has the lower trailing P/E: JAZZ trades at 15.82 and SOLV at 10.63. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, JAZZ or SOLV?: Over the past five years, JAZZ grew revenue faster — JAZZ at a 11.87% CAGR versus SOLV at 2.72%.
Is JAZZ or SOLV more profitable?: JAZZ runs the higher net margin — JAZZ at 20.45% versus SOLV at 17.26%.

Go deeper

Full JAZZ analysis Full SOLV analysis Interactive comparison tool

Dig into the metrics

Jazz Pharmaceuticals P/E ratio Solventum P/E ratio Jazz Pharmaceuticals ROE Solventum ROE Jazz Pharmaceuticals operating margin Solventum operating margin Jazz Pharmaceuticals revenue growth Solventum revenue growth Jazz Pharmaceuticals free cash flow Solventum free cash flow

Jazz Pharmaceuticals & Solventum appear in these rankings

Highest ROE Stocks Highest FCF Yield Stocks Lowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.